On Manufacturer Allocation
The two peptides act on non-overlapping points of the tissue-repair cascade: BPC-157 drives angiogenic and growth-factor signaling, including VEGF/VEGFR2 engagement and nitric-oxide pathway modulation, while TB-500 (thymosin -4) sequesters monomeric G-actin to modulate cytoskeletal remodeling and cell migration
"Amy is incredibly helpful, quick to respond to any questions, and super knowledgeable
For oral administration, clinical trials have studied doses ranging from 1-30 mg daily, with typical protocols using 1-2 mg per dose on an empty stomach
If you're already successful with diet and exercise, adding expensive weight loss peptides may offer marginal benefit for high cost
BPC-157 / TB-500 Mix Research Peptide Blend (Lyophilised, HPLC 99%) 60.00